Sumitomo Dainippon Pharma Co Ltd - Begin Period Cashflow

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Begin-Period-Cashflow" stands at 228.04 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Sumitomo Dainippon Pharma Co Ltd's second quarter result of 20.45 Billion JPY for the item "Begin Period Cashflow" represents a decrease of -11.52 percent compared to it's first quarter result.

Also, Sumitomo Dainippon Pharma Co Ltd's second quarter result of 20.45 Billion JPY for the item "Begin Period Cashflow" represents a decrease of -73.91 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's second quarter result of 228.04 Billion JPY for the item "Begin Period Cashflow" represents a decrease of -20.26 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.62 percent compared to the value the year prior.
The 1 year change in percent is 11.62.
The 3 year change in percent is -71.89.
The 5 year change in percent is -55.21.

The Serie's long term average value is 496.98 Billion Japanese Yens. It's latest available value, on 09/30/2025, is 54.11 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2012, to it's latest available value, on 09/30/2025, is +175.19%.
The Serie's change in percent from it's maximum value, on 03/31/2023, to it's latest available value, on 09/30/2025, is -76.60%.